# Presentation: 489453

## NIDA Health Services Research

**NIDA Health Services Research**
**Task Force Report and Recommendations **
- Charge to Task Force
- Dissemination of research findings to practice
- Utilization of CTN as a platform for HSR
- Organization and leadership of HSR within  NIDA’s Divisions and Centers and other Federal agencies to ensure bi-directional approaches in intervention development and dissemination.

## NIDA Health Services Research

**NIDA Health Services Research**
**Task Force Report and Recommendations **
** ****Task Force**
**   ****Andrea Barthwell, M.D.****	****	**** Richard Frank, Ph.D.**
**   ****Caryn Blitz, Ph.D.****	****	****	**** Warren Hewitt, M.S.**
**   ****Rick Catalano, Ph.D.****	****	****	**** James Inciardi, Ph.D.**
**   ****Mady Chalk, Ph.D.****	****	****	**** Marguerita Lightfoot, Ph.D.**
**   ****Linda Chinnia, M.Ed.****	****	****	**** Isaac Montoya, Ph.D.**
**   ****Lorraine Collins, Ph.D.****	****	**** Claire Sterk, Ph.D.**
**   ****Wilson Compton, M.D., M.P.E.****	**** Janet Wood, M.B.A., M.Ed.**
**   ****Michael Dennis, Ph.D.****	**
**  ****Co-Chairs:  Thomas McLellan, Ph.D.,**
**	****         ****Constance Weisner, Dr.P.H., M.S.W.**

## DEFINITION

**DEFINITION**
**         **

-     **Health services research is a multidisciplinary field of inquiry, both basic and applied, that examines how social factors, financing systems, organizational structures and processes, health technologies, and personal beliefs and behaviors affect access to and utilization of healthcare, the quality and cost of healthcare, and in the end our health and well-being. Ultimately, the goals of health services research are to identify the most effective ways to organize, manage, finance, and deliver high quality care.**** **

## Unique Features of Drug Abuse Prevention & Treatment

**Unique Features of Drug Abuse Prevention & Treatment**
- Services delivered in multiple types of settings
- Medications are rarely a part of treatment
- Non-voluntary treatment
- Important relationship with SAMHSA and
-   ONDCP
- Policies from other sectors impact services

## NIDA Health Services Research

**NIDA Health Services Research**
**Blue Ribbon Task Force  **
**Report and Recommendations **
**  ****Definition**
**  ****Critical First Steps:  Priorities and Indicators of Change**** **
**  ****Recommendations**
**      ****1.   Prevention Services Research**
**      ****2.   Treatment Services Research**
**      ****3.   Leading and Managing Services Research at NIDA**
**      ****4.   Services Research Collaborations within the NIH**
**             ****and with External Partners**

##       Goal I.   NIDA management must develop a clear  

**    ****CRITICAL FIRST STEPS: **
** ****PRIORITIES AND INDICATORS  OF CHANGE**
**      ****Goal I.   NIDA management must develop a clear  **
**      ****understanding drug abuse services research; and how**
**      ****it can serve NIDA’s broader mission of contributing to the**
**      ****health of the public.**
**      **

##       Goal II.  NIDA/DESPR should increase its portfolio of research

**    ****CRITICAL FIRST STEPS: **
** ****PRIORITIES AND INDICATORS  OF CHANGE**
**      ****Goal II.  NIDA/DESPR should increase its portfolio of research**
**      ****on  prevention and treatment systems, and on organizational, **
**      ****management, financing practices, policies, and cost.**
**	**

##    Goal III.  There is a need for NIDA leadership and collaboration

**CRITICAL FIRST STEPS:**
**PRIORITIES AND INDICATORS OF CHANGE**
**   ****Goal III.  There is a need for NIDA leadership and collaboration**
**   ****in the development of standards for evidence-based practice.**** **

##    Goal IV.   Given the complexity of the issues affecting drug

**CRITICAL FIRST STEPS:**
**PRIORITIES AND INDICATORS OF CHANGE**
**  **
**   ****Goal IV.   Given the complexity of the issues affecting drug**
**   ****abuse prevention and treatment as well as an understanding**
**   ****of the appropriate role of services research – it is imperative**
**   ****for NIDA to collaborate:  **
***     *****   ****-***** *****Across NIDA Divisions, Centers, and Branches **
**        ****- With other NIH Institutes **
**        ****- With SAMHSA and other Federal Agencies**** **

## Slide 10